Calypte Biomedical

Calypte Biomedical develops, manufactures, and distributes in vitro diagnostic tests primarily for the diagnosis.

Calypte Biomedical Corporation develops in vitro testing products to improve the diagnosis of Human Immunodeficiency Virus (HIV) infection, sexually transmitted diseases and other chronic diseases.Aware HIV-1/2 OMT is such type of product.Our innovative product line includes both point-of-care rapid tests and traditional EIA diagnostic tests. Calypte is a pioneer in non-blood-based HIV antibody testing. We’re the first and only company to earn approval from the U.S. Food and Drug Administration for a urine-based HIV-1 antibody-screening test and supplemental Western blot.Today, our Aware family of rapid oral fluid HIV tests offers unrivalled HIV 1/2 testing flexibility in a non-laboratory setting.